A recombinant form of IL-1Ra is commercially available and is known as anakinra, commonly used to treat arthritis and recently repurposed also for anti-cancer therapies against bone metastases to antagonize the many pro-tumor activities of IL-1β [21]. The gene discussed is IL1B; the disease is cancer.